Immunic News

Hold Rating on Immunic Amidst Ongoing Vido Clinical Trials and Financial Outlook

TipRanksMay 10 01:26 ET

Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP) and Immunic (IMUX)

TipRanksApr 16 02:50 ET

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), DocGo (DCGO) and Alkermes (ALKS)

TipRanksApr 10 07:20 ET

Immunic Analyst Ratings

BenzingaApr 5 04:57 ET

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Shockwave Medical (SWAV)

TipRanksApr 5 04:50 ET

Hold Rating on Immunic: Balancing Long-Term Potential Against Short-Term Uncertainties

TipRanksFeb 25 23:29 ET

Buy Rating Affirmed for Immunic Amid Progress in IMU-838 Trials and Extended Financial Runway

TipRanksFeb 22 13:36 ET

Analysts Offer Insights on Healthcare Companies: Trevena (TRVN) and Immunic (IMUX)

TipRanksNov 14, 2023 14:40 ET

Wedbush Maintains Outperform on Immunic, Raises Price Target to $7

BenzingaOct 10, 2023 09:02 ET

Immunic Analyst Ratings

BenzingaOct 10, 2023 09:01 ET

Buy Rating Assigned to Immunic Following Promising Interim Results of IMU-838 in Progressive Multiple Sclerosis Treatment

TipRanksOct 10, 2023 06:46 ET

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Amgen (AMGN) and Neurocrine (NBIX)

TipRanksOct 6, 2023 07:21 ET

Wedbush Sticks to Its Buy Rating for Immunic (IMUX)

TipRanksAug 4, 2023 06:55 ET

Immunic Analyst Ratings

BenzingaJul 27, 2023 08:20 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Pro Medicus Limited (OtherPMCUF) and Immunic (IMUX)

TipRanksJul 27, 2023 07:40 ET

Wedbush Keeps Their Buy Rating on Immunic (IMUX)

TipRanksMay 16, 2023 06:45 ET

Immunic (IMUX) Receives a Rating Update From a Top Analyst

TipRanksMay 15, 2023 06:06 ET

Immunic (IMUX) Receives a Rating Update From a Top Analyst

TipRanksMay 5, 2023 11:21 ET

Wedbush Keeps Their Buy Rating on Immunic (IMUX)

TipRanksMay 5, 2023 07:07 ET

Piper Sandler Gives a Buy Rating to Immunic (IMUX)

TipRanksApr 21, 2023 08:08 ET